Choose your location
Select your country or region to view content specific to your country.
Product News You can check out the latest product information
-
Obtained CE-IVD marking for Anyplex™ MTB/NTM Real-time Detection
Anyplex™ MTB/NTM Real-time DetectionIdentification of MTB dissociated from NTM Seegene's Anyplex™ MTB/NTM Real-time Detection?has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.
Jul 12, 2010｜ Anyplex™ MTB/NTM Real-time Detection
-
Launched Magicplex™ MTB Amplification
Magicplex™ MTB Amplification1 Detection of MTB1Using READ™ technology, this product simultaneously detects both IS6110 and MPB64 genes in tuberculosis bacilli and tests for Mycobacterium tuberculosis (MTB), through Real-time PCR.Testing for IS6110 & MPB64 genes IS6110 is an insertion sequence present in the MTB genome. As most MTB have one to twenty copies of it, its presence is a useful indicator in tuberculosis tests. There have, however, been reports of MTB strains without this gene, and in such a case, the accuracy of diagnosis can be enhanced by testing simultaneously for IS6110 and MPB64, which is a conserved sequence present in single copy in the MTB genome. This product is designed to detect both genes, significantly improving sensitivity. Molecular detection of MTB Acid-fast bacilli (AFB) smears and culture tests have been conventionally used in the diagnosis of tuberculosis. Although AFB smears are simple and fast, they suffer from low sensitivity and specificity; culture tests are the most accurate among the standard methods, but take a long time, approximately 8 weeks, to produce results. On the other hand, nucleic acid amplification, which has emerged recently as a promising method with the advances in molecular diagnostic technology, detects MTB directly from the sample, and it is being used widely due to its high sensitivity and its ability to produce results quickly.
Feb 07, 2010｜ Magicplex MTB Amplification
-
Launched Magicplex™ MTB Real-Time Detection
Detection of MTB1Using READ™ technology, this product simultaneously detects both IS6110 and MPB64 genes in tuberculosis bacilli and tests for Mycobacterium tuberculosis (MTB), through Real-time PCR. Testing for IS6110 & MPB64 genes IS6110 is an insertion sequence present in the MTB genome. As most MTB have one to twenty copies of it, its presence is a useful indicator in tuberculosis tests. There have, however, been reports of MTB strains without this gene, and in such a case, the accuracy of diagnosis can be enhanced by testing simultaneously for IS6110 and MPB64, which is a conserved sequence present in single copy in the MTB genome. This product is designed to detect both genes, significantly improving sensitivity. Molecular detection of MTB Acid-fast bacilli (AFB) smears and culture tests have been conventionally used in the diagnosis of tuberculosis. Although AFB smears are simple and fast, they suffer from low sensitivity and specificity; culture tests are the most accurate among the standard methods, but take a long time, approximately 8 weeks, to produce results. On the other hand, nucleic acid amplification, which has emerged recently as a promising method with the advances in molecular diagnostic technology, detects MTB directly from the sample, and it is being used widely due to its high sensitivity and its ability to produce results quickly.
Feb 07, 2010｜ Magicplex MTB Real-Time Detection
-
Launched Magicplex™ HPV 16/18 Amplification
Magicplex™ HPV 16/18 Amplification Discrimination of HPV16 and HPV18 Using READ™ technology, this product detects and distinguishes between HPV 16 and HPV 18 viruses, which are the main cause of cervical cancer. Most cases of HPV infection end in natural recovery within several months, but in those cases where the infection persists for more than twelve months, it may lead to CIN (cervical intraepithelial neoplasia) and cervical cancer. In particular, it has been reported that HPV 16 and 18 cause approximately 70% of all cervical cancers worldwide.
Feb 06, 2010｜ Magicplex HPV 16/18 Amplification
-
Launched Magicplex™ HPV 16/18 Real-time Detection
Magicplex™ HPV 16/18 Real-time Detection Discrimination of HPV16 and HPV18 Using READ™ technology, this product detects and distinguishes between HPV 16 and HPV 18 viruses, which are the main cause of cervical cancer. Most cases of HPV infection end in natural recovery within several months, but in those cases where the infection persists for more than twelve months, it may lead to CIN (cervical intraepithelial neoplasia) and cervical cancer. In particular, it has been reported that HPV 16 and 18 cause approximately 70% of all cervical cancers worldwide.
Feb 06, 2010｜ Magicplex HPV 16/18 Real-time Detection
-
Launched Magicplex™ HSV 1/2 Amplification
Magicplex™ HSV 1/2 Amplification Simultaneous detection of Hepatitis A/B/C Using READ™ technology, this product simultaneously detects and discriminates between HSV 1 and HSV 2, on Real-time PCR. Herpes simplex Virus (HSV) Herpes simplex viruses 1 and 2 are two members of the herpes virus family, Herpesviridae, that infect humans. Both HSV 1 and 2 are ubiquitous and contagious. They lead to latent infection, recurring outbreaks, and permanent infection, and may cause pudendal and oral cancers. HSV 1 usually produces lesions on the face and in the mouth, and HSV 2 on the genitalia and the anus. Over 90% of adults carry the virus in a latent state, and over 80% of patients with cervical cancer occurring inside the vagina possess antibody for HSV 2. The main route of transmission for HSV 2 is sexual contact, and testing for HSV 2 infection may be considered as a step in preventing cervical cancer.
Feb 05, 2010｜ Magicplex HSV 1/2 Amplification
-
Launched Magicplex™ HSV 1/2 Real-Time Detection
Magicplex™ HSV 1/2 Real-Time Detection Simultaneous detection of HSV 1/2 Using READ™ technology, this product simultaneously detects and discriminates between HSV 1 and HSV 2, on Real-time PCR. Herpes simplex Virus (HSV) Herpes simplex viruses 1 and 2 are two members of the herpes virus family, Herpesviridae, that infect humans. Both HSV 1 and 2 are ubiquitous and contagious. They lead to latent infection, recurring outbreaks, and permanent infection, and may cause pudendal and oral cancers. HSV 1 usually produces lesions on the face and in the mouth, and HSV 2 on the genitalia and the anus. Over 90% of adults carry the virus in a latent state, and over 80% of patients with cervical cancer occurring inside the vagina possess antibody for HSV 2. The main route of transmission for HSV 2 is sexual contact, and testing for HSV 2 infection may be considered as a step in preventing cervical cancer.
Feb 05, 2010｜ Magicplex HSV 1/2 Real-Time Detection
-
Launched Magicplex™ MG/MH/UP Real-Time Test
Launched Magicplex™ MG/MH/UP Real-Time Test
Feb 04, 2010｜ Magicplex MG/MH/UP Real-Time Test